Latest Insider Transactions at Igm Biosciences, Inc. (IGMS)
This section provides a real-time view of insider transactions for Igm Biosciences, Inc. (IGMS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of IGM Biosciences, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of IGM Biosciences, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 29
2023
|
Michael Stewart Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
492
+11.94%
|
-
|
|
Sep 29
2023
|
Redmile Group, LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
492
+0.02%
|
-
|
|
Sep 29
2023
|
M Kathleen Behrens |
BUY
Grant, award, or other acquisition
|
Direct |
800
+11.48%
|
-
|
|
Sep 29
2023
|
Michael D Loberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,138
+50.0%
|
-
|
|
Sep 29
2023
|
Christina Teng Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
738
+1.8%
|
-
|
|
Sep 29
2023
|
Jakob Haldor Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
492
+0.59%
|
-
|
|
Sep 29
2023
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
1,108
+0.11%
|
-
|
|
Jul 03
2023
|
George Gauthier Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
936
-2.29%
|
$8,424
$9.42 P/Share
|
|
Jun 30
2023
|
Michael D Loberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,138
+50.0%
|
-
|
|
Jun 30
2023
|
M Kathleen Behrens |
BUY
Grant, award, or other acquisition
|
Direct |
800
+12.97%
|
-
|
|
Jun 30
2023
|
Christina Teng Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
738
+1.84%
|
-
|
|
Jun 30
2023
|
Christina Teng Topsoe |
BUY
Open market or private purchase
|
Indirect |
3,000
+23.44%
|
$27,000
$9.32 P/Share
|
|
Jun 30
2023
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
1,108
+0.11%
|
-
|
|
Jun 30
2023
|
Redmile Group, LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
492
+0.02%
|
-
|
|
Jun 30
2023
|
Michael Stewart Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
492
+13.56%
|
-
|
|
Jun 30
2023
|
Jakob Haldor Topsoe |
BUY
Grant, award, or other acquisition
|
Direct |
492
+0.6%
|
-
|
|
Jun 30
2023
|
Jakob Haldor Topsoe |
BUY
Open market or private purchase
|
Direct |
3,500
+4.11%
|
$31,500
$9.25 P/Share
|
|
Jun 29
2023
|
Redmile Group, LLC Director |
BUY
Other acquisition or disposition
|
Indirect |
54,740
+1.81%
|
$492,660
$9.42 P/Share
|
|
Jun 29
2023
|
Redmile Group, LLC Director |
SELL
Other acquisition or disposition
|
Indirect |
54,740
-1.84%
|
$492,660
$9.42 P/Share
|
|
Jun 29
2023
|
Redmile Group, LLC Director |
BUY
Open market or private purchase
|
Indirect |
80,423
+2.63%
|
$723,807
$9.42 P/Share
|
|
Jun 29
2023
|
Redmile Group, LLC Director |
SELL
Open market or private sale
|
Indirect |
80,423
-2.7%
|
$723,807
$9.42 P/Share
|
|
Jun 29
2023
|
Jakob Haldor Topsoe |
BUY
Open market or private purchase
|
Direct |
3,500
+4.29%
|
$31,500
$9.1 P/Share
|
|
Jun 26
2023
|
M Kathleen Behrens |
BUY
Open market or private purchase
|
Indirect |
112,500
+25.38%
|
$900,000
$8.0 P/Share
|
|
May 23
2023
|
Chris H Takimoto CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,259
-1.12%
|
$15,108
$12.66 P/Share
|
|
May 23
2023
|
Lisa Lynn Decker CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
1,259
-1.48%
|
$15,108
$12.66 P/Share
|
|
May 23
2023
|
George Gauthier Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,259
-1.49%
|
$15,108
$12.66 P/Share
|
|
May 23
2023
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
982
-0.35%
|
$11,784
$12.66 P/Share
|
|
May 23
2023
|
Fred Schwarzer CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
1,259
-0.51%
|
$15,108
$12.66 P/Share
|
|
May 23
2023
|
Misbah Tahir CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,259
-1.21%
|
$15,108
$12.66 P/Share
|
|
May 15
2023
|
Chris H Takimoto CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
962
+1.69%
|
$10,582
$11.71 P/Share
|
|
May 15
2023
|
Lisa Lynn Decker CHIEF BUSINESS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
961
+2.21%
|
$10,571
$11.71 P/Share
|
|
May 15
2023
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
960
+0.69%
|
$10,560
$11.71 P/Share
|
|
May 15
2023
|
Fred Schwarzer CEO AND PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
960
+0.77%
|
$10,560
$11.71 P/Share
|
|
May 15
2023
|
Misbah Tahir CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
398
+0.76%
|
$4,378
$11.71 P/Share
|
|
Apr 18
2023
|
Fred Schwarzer CEO AND PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
34,200
+21.89%
|
-
|
|
Apr 18
2023
|
Lisa Lynn Decker CHIEF BUSINESS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
8,497
+17.0%
|
-
|
|
Apr 18
2023
|
George Gauthier Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,334
+16.49%
|
-
|
|
Apr 18
2023
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
21,126
+13.27%
|
-
|
|
Apr 05
2023
|
George Gauthier Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
935
-2.69%
|
$11,220
$12.6 P/Share
|
|
Apr 04
2023
|
Misbah Tahir CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
26,250
+33.73%
|
-
|
|
Apr 04
2023
|
Chris H Takimoto CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
26,250
+32.29%
|
-
|
|
Apr 04
2023
|
Steven Weber PRINCIPAL ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
8,750
+50.0%
|
-
|
|
Apr 04
2023
|
Bruce Keyt CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
26,250
+18.33%
|
-
|
|
Apr 04
2023
|
Fred Schwarzer CEO AND PRESIDENT |
BUY
Grant, award, or other acquisition
|
Direct |
67,500
+43.45%
|
-
|
|
Apr 04
2023
|
Lisa Lynn Decker CHIEF BUSINESS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
16,250
+33.01%
|
-
|
|
Apr 04
2023
|
George Gauthier Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
16,250
+31.82%
|
-
|
|
Mar 31
2023
|
Michael Stewart Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
492
+15.69%
|
-
|
|
Mar 31
2023
|
Redmile Group, LLC Director |
BUY
Grant, award, or other acquisition
|
Indirect |
492
+0.01%
|
-
|
|
Mar 31
2023
|
M Kathleen Behrens |
BUY
Grant, award, or other acquisition
|
Direct |
800
+14.9%
|
-
|
|
Mar 31
2023
|
Michael D Loberg Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,138
+50.0%
|
-
|